Vestibular Schwannoma Organoids

Launched by MAASTRICHT RADIATION ONCOLOGY · Mar 14, 2023

Keywords

ClinConnect Summary

This clinical trial is studying a type of tumor called vestibular schwannoma, which affects the nerve involved in hearing and balance. Patients who have had an MRI that suggests they might have this tumor and are scheduled for surgery may be eligible to participate. During the surgery, doctors will collect a small amount of tissue from the tumor. The leftover tissue, which is not needed for medical analysis, will be used to create special lab-grown models called organoids. These organoids will help researchers learn more about vestibular schwannoma and how to treat it better in the future.

To be eligible for this trial, participants need to be at least 18 years old and have an MRI that shows signs of vestibular schwannoma. Those who are incapacitated or choose not to participate will not be included. If you decide to take part in the study, you can expect to contribute to important research that may help improve treatment options for future patients. Your participation could make a significant difference in understanding this condition better.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • MRI with suspicion for vestibular schwannoma
• • Indication for surgery in the skull base committee
• • 18 years or older
• Exclusion Criteria:
• • Refusal to participate
• • Younger than 18 years
• • Incapacitated